- Home
- SBCF vs ICUI Comparison
SBCF vs ICUI Comparison
Compare SBCF & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBCF
- ICUI
- Stock Information
- Founded
- SBCF 1926
- ICUI 1984
- Country
- SBCF United States
- ICUI United States
- Employees
- SBCF N/A
- ICUI N/A
- Industry
- SBCF Major Banks
- ICUI Medical/Dental Instruments
- Sector
- SBCF Finance
- ICUI Health Care
- Exchange
- SBCF Nasdaq
- ICUI Nasdaq
- Market Cap
- SBCF 2.8B
- ICUI 3.0B
- IPO Year
- SBCF N/A
- ICUI 1992
- Fundamental
- Price
- SBCF $30.59
- ICUI $129.10
- Analyst Decision
- SBCF Buy
- ICUI Buy
- Analyst Count
- SBCF 4
- ICUI 6
- Target Price
- SBCF $29.50
- ICUI $186.60
- AVG Volume (30 Days)
- SBCF 566.9K
- ICUI 269.3K
- Earning Date
- SBCF 10-23-2025
- ICUI 11-11-2025
- Dividend Yield
- SBCF 2.37%
- ICUI N/A
- EPS Growth
- SBCF 19.16
- ICUI N/A
- EPS
- SBCF 1.63
- ICUI N/A
- Revenue
- SBCF $531,697,000.00
- ICUI $2,372,504,000.00
- Revenue This Year
- SBCF $28.39
- ICUI N/A
- Revenue Next Year
- SBCF $34.82
- ICUI N/A
- P/E Ratio
- SBCF $18.63
- ICUI N/A
- Revenue Growth
- SBCF 5.40
- ICUI 2.96
- 52 Week Low
- SBCF $21.36
- ICUI $107.00
- 52 Week High
- SBCF $32.09
- ICUI $196.26
- Technical
- Relative Strength Index (RSI)
- SBCF 54.68
- ICUI 51.94
- Support Level
- SBCF $29.86
- ICUI $121.61
- Resistance Level
- SBCF $31.12
- ICUI $136.61
- Average True Range (ATR)
- SBCF 0.66
- ICUI 4.03
- MACD
- SBCF -0.15
- ICUI 0.24
- Stochastic Oscillator
- SBCF 32.74
- ICUI 49.93
About SBCF Seacoast Banking Corporation of Florida
Seacoast Banking Corp of Florida is a holding company for Seacoast National Bank. The company provides integrated financial services including commercial and consumer banking, wealth management, and mortgage and insurance services to customers across Florida, and through mobile and online banking solutions. In addition, it provides services such as treasury management, brokerage and credit facilities.
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.